Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00997347 · ClinicalTrials.gov registry record · Phase 4
The Extended Gestational Age Medical Abortion Study
A Phase 4 study, sponsored by Gynuity Health Projects.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,400
- Enrollment target
NCT00997347 is a Phase 4 study that has completed, run by Gynuity Health Projects. The registered enrollment target is 1,400 participants.
The verdict
NCT00997347, a Phase 4 study, has completed, sponsored by Gynuity Health Projects.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,400 participants
- Enrollment target
Study Summary
This open-label, comparative study will compare the efficacy, safety, and acceptability of 200 mg mifepristone followed in 24-48 hours by 800mcg buccal misoprostol or 400mcg sublingual misoprostol for termination of pregnancy in existing outpatient early medical abortion services among women 57-63 days' versus 64-70 days' gestation.
Interventions
- DRUG Mifepristone and misoprostol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,400 participants |
| Start Date | 2009-07 |
| Est. Completion | 2012-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00997347
The ClinicalTrials.gov registry entry for NCT00997347 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 1,400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gynuity Health Projects, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mifepristone and misoprostol is the first listed.
NCT00997347 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00997347 about?
NCT00997347 is a clinical study titled "The Extended Gestational Age Medical Abortion Study". This open-label, comparative study will compare the efficacy, safety, and acceptability of 200 mg mifepristone followed in 24-48 hours by 800mcg buccal misoprostol or 400mcg sublingual misoprostol for termination of pregnancy in existing outpatient early medical abortion services among women 57-63 d...
What is the current status of trial NCT00997347?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,400 participants. The study started on 2009-07. Estimated completion is 2012-02.
What interventions are being tested in trial NCT00997347?
The interventions under investigation include: Mifepristone and misoprostol (DRUG).
Who is sponsoring clinical trial NCT00997347?
This trial is sponsored by Gynuity Health Projects, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.